POSTER SESSION III
Tuesday, March 1, 2011 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
222
Extranodal Natural Killer/T-Cell Lymphomas in Jujuy North-West Argentina: A Clinic-Pathologic Study of 40 Cases.
(1311)
O Marin - Pablo Soria Hospital, S.S. Jujuy, Argentina
Extranodal NK/T-Cell Lymphoma, Nasal Type, a Retrospective Study of 50 Cases from the United States.
(1305)
S Li, X Feng, P Lin, S Konoplev, LJ Medeiros, CC Yin - The University of Texas MD Anderson Cancer Center, Houston
Extranodal NK/T-Cell Lymphomas, Nasal Type of γδ T-Cell Origin Are Not Rare.
(1343)
T Pongpruttipan, S Sukpanichnant, T Assanasen, P Wannakrairot, W Kanoksil, P Boonsakan, K Kayasut, W Mitarnun, A Garcia, E Campo, J Choi, SH Swerdlow - Siriraj Hosp, Bangkok, Thailand; Chulalongkorn Hosp, Bangkok, Thailand; Ramathibodi Hosp, Bangkok, Thailand; Prince of Songkla U, Hat-Yai, Thailand; U Barcelona, Spain; U Penn Sch of Med, Philadelphia; U Pitt Sch of Med, Pittsburgh
B-Cell Lymphoma Composite with T-Cell Malignancy: A Hidden Neoplastic Component; a Clinicopathological Study of 6 Cases.
(1336)
P Papavassiliou, CB Hutchinson, IN Siddiqi, RK Brynes, E Wang - Duke University Medical Center, Durham, NC; University of Southern California Medical Center, Los Angeles
A New Immunohistochemistry Method To Detect T-Cell Receptor gamma Chain Expression in Paraffin Embedded Biopsies Identifies a Unique Set of Peripheral T-Cell Lymphomas Co-Expressing T-Cell Receptor Beta and gamma Chains.
(1332)
N Ozsan, AF Feldman, BL Caron, JA Vrana, WG Morice, WR Macon, PJ Kurtin, A Dogan, KL Grogg - Mayo Clinic, Rochester, MN
Clinical Implications of the Expression of TCR and NF-KB Pathway Genes in Nodal Peripheral T-Cell Lymphomas.
(1351)
SM Rodriguez-Pinilla, ME Casttillo Sanchez, C Gonzalez, J Rodriguez, C Gomez-Abad, L Ferrando Lamana, G Sosa, JC Rivero, J Menarguez, I Blanco Gomez, F Camacho, P Ramos Guillen, C Perez Seoane Orduna, C Barrionuevo, M Mollejo, MA Piris - CNIO, Madrid, Spain; 12 de Octubre Hospital, Madrid, Spain; Alcorcon Hospital, Madrid, Spain; Dr Negrin Hospital, Gran Canaria, Spain; Gregorio Maranon Hospital, Madrid, Spain; General Segovia Hospital, Segovia, Spain; Getafe University Hospital, Madrid, Spain; Principe de Asturias University Hospital, Alcala de Henares,Madrid, Spain; Reina Sofia University Hospital, Cordoba, Spain; INEN, Lima, Peru; Virgen de la SAlud Hospital, Toledo, Spain
Variability of Foxp3 Expression in Adult T-Cell Leukemia/Lymphoma (ATLL) in US/Caribbean Cases.
(1403)
J Yao, SRS Gottesman, G Ayalew, AS Braverman, CA Axiotis - SUNY Downstate Medical Center, Brooklyn, NY; Kings County Hospital Center, Brooklyn, NY
Expression of Thymidine Phosphorylase in Lymph Nodes with Mycosis Fungoides Involvement.
(1326)
X Nie, R Bhat, E Dulaimi Al-Saleem, E Vonderheid, JS Hou - Drexel University College of Medicine, Philadelphia, PA; Johns Hopkins Medical Institutes, Baltimore, MD
Is the Sezary Cell Losing It? Cell Cycle Related Proteins in Lymph Nodes with Mycosis Fungoides.
(1325)
X Nie, R Bhat, E Dulaimi Al-Saleem, E Vonderheid, JS Hou - Drexel University College of Medicine, Philadelphia, PA; Johns Hopkins Medical Institutes, Baltimore, MD
Immunophenotypic Stability of Sezary Cells by Flow Cytometry.
(1384)
J Vaughan, AM Harrington, SH Kroft, H Olteanu - Medical College of Wisconsin, Milwaukee
Expansion of an Immunophenotypically Distinct Cytotoxic T-Cell Population Following Autologous Stem Cell Transplant in Plasma Cell Myeloma.
(1400)
K Wolniak, C Goolsby, D Dittman, L Marszalek, S Singhal, J Mehta, LC Peterson - Feinberg School of Medicine, Northwestern University, Chicago, IL
Genetic Abnormality in T-Cell Large Granular Lymphocyte Leukemia . Single Nucleotide Polymorphism Array Study of 30 Cases.
(1409)
W Zeng, CL O'Keefe, M Clemente, JP Maciejewski, E Hsi - Cleveland Clinic, OH
Histiocytic and Dendritic Cell Neoplasms: A Clinicopathologic Study of 15 Cases.
(1361)
R Setoodeh, L Moscinski, L Sokol, M Naghashpour - Moffitt Cancer Center, Tampa, FL
Langerhans Cell Histiocytosis in Acute Leukemia in Adult Patients: A Unique Entity?
(1406)
SL Yohe, C Chenault, E Torlakovic, S Asplund, RW McKenna - University of Minnesota, Minneapolis; ProPath Laboratories, Dallas, TX; University of Toronto, ON, Canada; Caris Life Sciences, Phoenix, AZ
Flow Cytometric Findings in Hemophagocytic Lymphohistiocytosis.
(1315)
CM McCall, S Fuller, S Mudali, RJ Arceci, CD Gocke, M Vuica-Ross, KH Burns, MJ Borowitz, AS Duffield - Johns Hopkins, Baltimore, MD
Expression and Diagnostic Utility of CD200 in Hematologic Malignancies.
(1242)
J Coviello-Malle, D Alapat, B Barlogie, JD Shaughnessy, RB Lorsbach - University of Arkansas for Medical Sciences, Little Rock
Analysis of Aberrant Expression of CD56 and CD117 in Plasma Cell Neoplasms.
(1321)
EA Morgan, B Li, A Shahsafaei, DM Dorfman, O Pozdnyakova - Brigham & Women's Hospital, Boston, MA
Functional and Therapeutic Relevance of CD56(NCAM) Expression in Multiple Myeloma.
(1263)
S Gattenlohner, A Mottok, T Stuhmer, R Bargou, H Einsele, H-K Muller-Hermelink - Institute fo Pathology, Medical University of Graz, Graz, Germany; University of Wurzburg, Germany; Institute of Pathology, University of Wurzburg, Germany
CD45 Expression in Plasma Cell Myeloma: Comparison of Flow Cytometry and Immunohistochemistry and Relationship to Prognostic Factors.
(1348)
SK Rathke, H Olteanu, SH Kroft, AM Harrington - Medical College of Wisconsin, Milwaukee
Clinicopathologic Analysis of the Impact of CD23 Expression in Plasma Cell Myeloma with t(11;14)(q13;q32).
(1225)
JN Buonaccorsi, SH Kroft, A Harrington, P VanTuinen, H Olteanu - Medical College of Wisconsin, Milwaukee
Plasma Cell Myeloma with IGHV Deletion: A Subset of Patients with Poor Prognosis.
(1309)
G Lu, S Li, F Alseraye, R Muddasani, L Abruzzo, M Wang, JM You, LJ Medeiros - UT MD Anderson Cancer Center, Houston, TX
CKS1B Nuclear Expression Predicts an Adverse Outcome for Multiple Myeloma Patients Treated with Bortezomib.
(1233)
M-H Chen, C Qi, H Chang - University Health Network, Toronto, Canada
Activation of the PI3K/Akt Pathway in Plasma Cell Myeloma Is Associated with MAF and DEPTOR Overexpression and Favorable Response to Therapy.
(1323)
V Nardi, H Rochelle-Keyes, T Peterson, M Loda, L Rosina, N Raje, AR Sohani, DM Sabatini, RP Hasserjian - Massachusetts General Hospital, Boston; Whitehead Institute, Cambridge, MA; Dana Farber Cancer Institute, Boston, MA
Prima-1met Induces Cytotoxicity in Multiple Myeloma Cells Irrespective of p53 Status and Displays a Synergistic Cytotoxic Response with Conventional Chemotherapeutic Drugs.
(1286)
H Jiang, MN Saha, M-H Chen, H Chang - University Health Network, Toronto, Canada
Analysis of Allelic Loss of Tumor Suppressor Gene ING4 in Plasma Cell Dyscrasias.
(1345)
C Qi, J Nancy, L Yu, N Yi, H Chang - University Health Network, Toronto, Canada; University of Maryland, Baltimore
RITA Induces Cytotoxicity and Apoptosis in Multiple Myeloma Cells Harbouring Wild Type p53: Evidence for Synergistic Cytotoxic Responses with Conventional Chemotherapeutic Drugs.
(1356)
MN Saha, H Jiang, DR Branch, H Chang - University Health Network, Toronto, ON, Canada
P53 Nuclear Expression Correlates with Hemizygous p53 Deletion and Has an Adverse Impact on the Outcome of Refractory/Relapsed Multiple Myeloma Patients Treated with Lenalidomide.
(1232)
M-H Chen, C Qi, H Chang - University Health Network, Toronto, Canada
Impact of Genetic Risk Factors on the Outcome of Relapsed/Refractory Multiple Myeloma in the Era of Novel Therapies.
(1289)
A Jiang, C Qi, Y Trieu, D Reece, H Chang - University Health Network, Toronto, Canada
Clinical Significance of ATM (Ataxia .Telangiectasia Mutated) and C-Myc Proteins in Multiple Myeloma Cases Treated with Valcade.
(1319)
Z Mohammad Taheri, A Mansoor, N Bahlis, M-T Shabani-Rad - University of Calgary, AB, Canada
button next to any title to add to Itinerary Planner...
Add
